Common Comorbid Condition of Patients With Autism Spectrum Disorder and Pharmacotherapy for Patients With Autism Spectrum Disorder

被引：1

作者：

Chung, Un Sun ^{[1
]}

Kim, Ji-Hoon ^{[2
,3
]}

机构：

[1] Kyungpook Natl Univ, Sch Med, Dept Psychiat, Daegu, South Korea

[2] Pusan Natl Univ, Sch Med, Dept Psychiat, Yangsan, South Korea

[3] Pusan Natl Univ, Sch Med, Dept Psychiat, 20 Geumo Ro, Yangsan 50612, South Korea

来源：

JOURNAL OF THE KOREAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2024年 / 35卷 / 01期

关键词：

Autism; Comorbidity; Pharmacotherapy; Guideline; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CHILDREN; ADOLESCENTS; IRRITABILITY; ARIPIPRAZOLE; RISPERIDONE; CLONIDINE; THERAPY; NETWORK;

D O I：

10.5765/jkacap.230006

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article describes common comorbid condtion of the autism spectrum disorder (ASD) and recommends treatment guidelines of pharmacotherapy for patients with ASD. More than 95% of people with ASD have at least one additional disorder and guidelines how to evaluate and treat comorbid conditions in patients with ASD and 7 recommendations for treatment with medication for ASD.

引用

页码：39 / 43

页数：5

共 44 条

[1]

Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266

[2] Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension [J].

Aman, Michael G. ;

Findling, Robert L. ;

Hardan, Antonio Y. ;

Hendren, Robert L. ;

Melmed, Raun D. ;

Kehinde-Nelson, Ola ;

Hsu, Hai-An ;

Trugman, Joel M. ;

Palmer, Robert H. ;

Graham, Stephen M. ;

Gage, Allyson T. ;

Perhach, James L. ;

Katz, Ephraim .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (05) :403-412

[3]

America Psychiatric Association, WHAT IS AUT SPECTR D

[4]

[Anonymous], through coadministration of FDA-approved immunomodulators and

[5]

[Anonymous], 2011, Autism spectrum disorder in under 19s: Recognition, referral and diagnosis

[6]

[Anonymous], 2008, AUTISM SPECTRUM DISO

[7] Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up [J].

Bernaerts, Sylvie ;

Boets, Bart ;

Bosmans, Guy ;

Steyaert, Jean ;

Alaerts, Kaat .

MOLECULAR AUTISM, 2020, 11 (01)

[8]

Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1

[9] Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial [J].

Cortesi, Flavia ;

Giannotti, Flavia ;

Sebastiani, Teresa ;

Panunzi, Sara ;

Valente, Donatella .

JOURNAL OF SLEEP RESEARCH, 2012, 21 (06) :700-709

[10] A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder [J].

Dean, Olivia M. ;

Gray, Kylie M. ;

Villagonzalo, Kristi-Ann ;

Dodd, Seetal ;

Mohebbi, Mohammadreza ;

Vick, Tanya ;

Tonge, Bruce J. ;

Berk, Michael .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 (03) :241-249

← 1 2 3 4 5 →